Table 1.

ADNI study design.

	Participants*					Data collection
	CN	EMCI	MCI	LMCI	AD	MRI	fMRIa	DTIb	FDG	AV45c	PiB	Biosd
ADNI-1	200	–	400	–	200	X			X		X	X
ADNI-GO	↓	200	↓	–	–	X	X	X	X	X		X
ADNI-2	150	150	↓	150	200	X	X	X	X	X		X

^afMRI, functional MRI;

^bDTI, diffusion tensor imaging;

^cAV45, florbetapir PET amyloid imaging;

^dBios, biological samples.

^*Numbers are study targets, not final statistics. Arrows indicate that study participants continued longitudinally in later phases of ADNI.